Viewing Study NCT04834635


Ignite Creation Date: 2025-12-24 @ 10:30 PM
Ignite Modification Date: 2025-12-31 @ 4:43 PM
Study NCT ID: NCT04834635
Status: COMPLETED
Last Update Posted: 2025-04-02
First Post: 2021-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The FundoRingOAGB Versus Non-wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009767', 'term': 'Obesity, Morbid'}, {'id': 'D009765', 'term': 'Obesity'}], 'ancestors': [{'id': 'D050177', 'term': 'Overweight'}, {'id': 'D044343', 'term': 'Overnutrition'}, {'id': 'D009748', 'term': 'Nutrition Disorders'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D001835', 'term': 'Body Weight'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 1000}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-03-29', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-01', 'completionDateStruct': {'date': '2024-12-31', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2025-03-27', 'studyFirstSubmitDate': '2021-04-04', 'studyFirstSubmitQcDate': '2021-04-04', 'lastUpdatePostDateStruct': {'date': '2025-04-02', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-04-08', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-04-05', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change of body mass index', 'timeFrame': 'Baseline, at 12, 24, 36 months after surgery', 'description': 'The measure is assessing a change of body mass index. Weight (kg) and height (cm) will be combined with the report of measurement by body mass index (BMI) kg/m2.'}], 'secondaryOutcomes': [{'measure': 'Postoperative bile reflux in esophagus', 'timeFrame': 'at 12, 24, 36 months after surgery', 'description': 'The endoscopic finding of postoperative bile reflux in the esophagus'}, {'measure': 'GERD symptoms', 'timeFrame': 'Baseline, 12, 24, 36 months after surgery', 'description': 'Change og GERD symptoms if present GERD or postoperative de Novo GERD symptoms (GERD-HRQL)'}, {'measure': 'Oral glucose tolerance tests', 'timeFrame': 'Blood samples for glucose collects at 0, 15, 30, 60, 120, 150 and 180 minutes, while those for insulin collects at 0, 30, 60, 120 and 180 minutes', 'description': 'A 3-hour oral glucose tolerance tests performs using 75 g glucose'}, {'measure': 'Sigstad score', 'timeFrame': '6, 12, 24, 36 months after surgery', 'description': 'Sigstad score for questionnaire of diagnostic the dumping syndrome'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Obesity', 'Bariatric surgery', 'One anastomosis gastric bypass', 'FundoRingOAGB', 'Fundoplication'], 'conditions': ['Obesity, Morbid']}, 'referencesModule': {'references': [{'pmid': '35392958', 'type': 'RESULT', 'citation': 'Ospanov O, Yeleuov G, Fursov A, Yelembayev B, Fursov R, Sergazin Z, Mustafin A. A laparoscopic one anastomosis gastric bypass with wrapping versus nonwrapping fundus of the excluded part of the stomach to treat obese patients (FundoRingOAGB trial): study protocol for a randomized controlled trial. Trials. 2022 Apr 7;23(1):264. doi: 10.1186/s13063-022-06252-6.'}, {'pmid': '36800158', 'type': 'RESULT', 'citation': 'Ospanov O. The Surgical Technique of Primary Modified Fundoplication Using the Excluded Stomach with Simultaneous Gastric Bypass. Obes Surg. 2023 Apr;33(4):1311-1313. doi: 10.1007/s11695-023-06505-6. Epub 2023 Feb 17.'}, {'pmid': '37099252', 'type': 'RESULT', 'citation': 'Ospanov O, Yeleuov G, Buchwald JN, Zharov N, Yelembayev B, Sultanov K. A Randomized Controlled Trial of Acid and Bile Reflux Esophagitis Prevention by Modified Fundoplication of the Excluded Stomach in One-Anastomosis Gastric Bypass: 1-Year Results of the FundoRing Trial. Obes Surg. 2023 Jul;33(7):1974-1983. doi: 10.1007/s11695-023-06618-y. Epub 2023 Apr 26.'}, {'pmid': '34059995', 'type': 'DERIVED', 'citation': 'Ospanov OB. The Gastric Bypass and Fundoplication in Bariatric Surgery: the Comments on Published Papers and Our Classification of Combination Procedures. Obes Surg. 2021 Oct;31(10):4643-4644. doi: 10.1007/s11695-021-05505-8. Epub 2021 Jun 1.'}], 'seeAlsoLinks': [{'url': 'http://pubmed.ncbi.nlm.nih.gov/35392958/', 'label': 'A laparoscopic one anastomosis gastric bypass with wrapping versus nonwrapping fundus of the excluded part of the stomach to treat obese patients (FundoRingOAGB trial): study protocol for a randomized controlled trial'}, {'url': 'http://pubmed.ncbi.nlm.nih.gov/36800158/', 'label': 'The Surgical Technique of Primary Modified Fundoplication Using the Excluded Stomach with Simultaneous Gastric Bypass'}, {'url': 'https://pubmed.ncbi.nlm.nih.gov/37099252/', 'label': 'A Randomized Controlled Trial of Acid and Bile Reflux Esophagitis Prevention by Modified Fundoplication of the Excluded Stomach in One-Anastomosis Gastric Bypass: 1-Year Results of the FundoRing Trial'}]}, 'descriptionModule': {'briefSummary': 'Currently, one anastomosis gastric bypass (OAGB) or mini-gastric bypass (MGB) is a common bariatric procedure for treating obesity. Weight gain after surgery is a big problem in bariatric practice. Therefore, adjustable bands and rings are used, for example, "FobiRing". But foreign material can cause complications - the erosion of the stomach wall. For this reason, surgeons avoid the use of various mechanical devices on living tissues.\n\nThe greatest criticism is of the OAGB for the likelihood of biliary reflux. In case of reflux of bile into the esophagus after surgery, as a rule, a second operation is required with conversion OAGB to the Roux-en-Y method.\n\nIn addition, along with obesity, gastroesophageal reflux disease (GERD) are steadily increasing world weight and antireflux surgery must be performed simultaneously with bariatric surgery in obese patients. In these cases, most often in bariatric practice, hiatus cruroraphy is performed, and less often fundoplication using the fundus of the excluded part of the stomach.\n\nWe hypothesize that total fundoplication can not only treat GERD but also significant prevent the return of weight like after a banded gastric bypass and prevent postoperative bile reflux in the esophagus.\n\nThe aim study is to compare primary outcome as weight loss after total wrapping of the fundus of the gastric excluded part (FundoRing) and non - wrapping (non - banded) standard method of laparoscopic one anastomosis gastric bypass and measure secondary outcome: bile reflux in the esophagus and GERD symptoms.\n\nMethods: Adult participants (n=1000) are randomly allocated to one of two groups:\n\nExperimental surgical bariatric procedure in the first (A) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and suture cruroplasty if present hiatal hernia (FundoRingOAGB group); Active comparator surgical bariatric procedure in the second (B) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass and with only suture cruroplasty if present hiatal hernia (OAGB group).', 'detailedDescription': 'One anastomosis Gastric Bypass/Mini Gastric Bypass (OAGB/MGB) is gaining popularity as a primary surgical treatment for morbid obesity.\n\nThe aim study is to compare primary outcome as weight loss after total wrapping of the fundus of the gastric excluded part (FundoRing) and non - wrapping (non - banded) standard method of laparoscopic one anastomosis gastric bypass and measure secondary outcome: bile reflux in the esophagus and GERD symptoms.\n\nMethods: Adult participants (n=1000) are randomly allocated to one of two groups:\n\nExperimental surgical bariatric procedure in the first (A) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and suture cruroplasty if present hiatal hernia (FundoRingOAGB group); Active comparator surgical bariatric procedure in the second (B) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass and with only suture cruroplasty if present hiatal hernia (OAGB group). All patients are then followed up 12, 24, 36 months after surgery where record the changing body mass index and and measure secondary outcome: bile reflux in the esophagus and GERD symptoms.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '60 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* BMI from 30 to 50 kg / m2.\n* The person is generally fit for anesthesia (ASA grading 1-2) and surgery.\n* The person commits to the need for long-term follow-up.\n\nExclusion Criteria:\n\n* BMI less than 30 kg / m2 and more than 50 kg / m2.\n* Prosthetic (mesh) Hiatal herniorrhaphy or large hiatal hernia;\n* Esophageal shortening\n* Los Angeles Classification of Oesophagitis (LA grade) C or D reflux esophagitis\n* History of surgery on the stomach or esophagus\n* Less than 18 or more than 60 years of age\n* Not fit for bariatric surgery\n* Psychiatric illness\n* Patients unwilling or unable to provide informed consent'}, 'identificationModule': {'nctId': 'NCT04834635', 'acronym': 'FundoRingMGB', 'briefTitle': 'The FundoRingOAGB Versus Non-wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass', 'organization': {'class': 'OTHER', 'fullName': 'The Society of Bariatric and Metabolic Surgeons of Kazakhstan'}, 'officialTitle': 'The Total Wrapping of the Fundus of the Gastric Excluded Part (FundoRing) Versus Non- Wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass/Mini - Gastric Bypass: A Randomized Controlled Trial', 'orgStudyIdInfo': {'id': 'FundoRingOAGB'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'FundoRingOAGB group', 'description': 'laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part (and suture cruroplasty if present hiatal hernia).', 'interventionNames': ['Procedure: FundoRingOAGB']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'OAGB group', 'description': 'laparoscopic one anastomosis gastric bypass (and suture cruroplasty if present hiatal hernia).', 'interventionNames': ['Procedure: OAGB']}], 'interventions': [{'name': 'FundoRingOAGB', 'type': 'PROCEDURE', 'description': 'laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and with suture cruroplasty if present hiatal hernia', 'armGroupLabels': ['FundoRingOAGB group']}, {'name': 'OAGB', 'type': 'PROCEDURE', 'description': 'laparoscopic one anastomosis gastric bypass with suture cruroplasty if present hiatal hernia', 'armGroupLabels': ['OAGB group']}]}, 'contactsLocationsModule': {'locations': [{'zip': '010000', 'city': 'Astana', 'country': 'Kazakhstan', 'facility': 'Oral Ospanov', 'geoPoint': {'lat': 51.1801, 'lon': 71.44598}}], 'overallOfficials': [{'name': 'Oral Ospanov', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'President of Society of Bariatric and Metabolic Surgeons of Kazakhstan" (SBMSK)'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'The Society of Bariatric and Metabolic Surgeons of Kazakhstan', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}